Ethical and policy issues in newborn screening of children for neurologic and developmental disorders

Area of Science:

• Medical Genetics
• Pediatric Neurology
• Developmental Biology

Background:

• Genetic testing is crucial for diagnosing and predicting neurologic and developmental disorders in children.
• Newborn screening programs in the United States are expanding to include a wider range of genetic conditions.
• Early detection through genetic screening enables timely intervention and management of childhood-onset diseases.

Purpose of the Study:

• To analyze the inclusion and implications of specific genetic disorders within newborn screening programs.
• To present case studies of Duchenne muscular dystrophy, Krabbe disease, and fragile X syndrome in the context of newborn screening.
• To discuss the spectrum of genetic testing from universal screening to diagnostic and predictive testing for pediatric conditions.

Main Methods:

• Review of existing newborn screening protocols and proposed additions.
• Analysis of three distinct case studies representing neuromuscular, neurodegenerative, and neurodevelopmental disorders.
• Examination of genetic testing strategies employed for childhood-onset conditions.

Main Results:

• Duchenne muscular dystrophy, Krabbe disease, and fragile X syndrome are key examples of disorders considered for or included in newborn screening.
• Newborn screening encompasses a range of genetic tests, from universal screening to diagnostic and predictive applications.
• The article utilizes case studies to illustrate the practical aspects of genetic screening for pediatric neurologic and developmental conditions.

Conclusions:

• Newborn screening programs are vital for the early identification of serious genetic disorders.
• The inclusion of conditions like Duchenne muscular dystrophy, Krabbe disease, and fragile X syndrome in screening reflects advancements in genetic testing and pediatric care.
• Genetic testing plays a multifaceted role in managing childhood neurologic and developmental disorders, from universal screening to targeted diagnostics.